Alexander Fiksdal1, Luke Hanlin1, Yuliya Kuras1, Danielle Gianferante1, Xuejie Chen1, Myriam V Thoma2, Nicolas Rohleder3. 1. Department of Psychology and Volen National Center for Complex Systems, Brandeis University, Waltham, MA, United States. 2. Division of Psychopathology and Clinical Intervention, University of Zurich, Zurich, Switzerland. 3. Department of Psychology and Volen National Center for Complex Systems, Brandeis University, Waltham, MA, United States; Chair of Health Psychology, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany. Electronic address: nicolas.rohleder@fau.de.
Abstract
BACKGROUND: Anxiety disorders and major depressive disorder (MDD) have been associated with increased and blunted HPA axis reactivity to social stress. However, research focusing on associations between HPA axis responses to stress and symptoms of anxiety and depression among individuals without a diagnosis remains an understudied area of research. METHODS: One hundred forty-three adults (52% female) completed the Trier Social Stress Test (TSST). Symptoms of depression and anxiety were assessed prior to the TSST using the anxiety and depression subscales of the Hospital Anxiety and Depression Scale (HADS). HPA axis responses were assessed by measuring salivary cortisol at baseline and following the TSST. Reactivity to and recovery from stress were assessed using multilevel growth modeling controlling for age, BMI, and sex among the full sample and a subset of cortisol responders (n = 72). RESULTS: Anxiety symptoms were positively associated with flatter recovery slopes among the full sample (t(122.3) = 2.082, p = .039). Among cortisol responders, depression symptoms were associated with steeper reactivity (t(63.32) = 2.53, p = .026) and recovery (t(58.75)=-2.20, p = .03). Anxiety symptoms were associated with marginally flatter reactivity (t(64.00)=-1.97, p = .053) and significantly flatter recovery (t(59.22) = 2.29, p = .025). CONCLUSION: Symptoms of anxiety and depression among individuals without a psychiatric diagnosis are associated with blunted and exaggerated cortisol responses to and recovery from stress. Such patterns could indicate increased risk for unhealthy HPA axis dysregulation, allostatic load, and disease.
BACKGROUND:Anxiety disorders and major depressive disorder (MDD) have been associated with increased and blunted HPA axis reactivity to social stress. However, research focusing on associations between HPA axis responses to stress and symptoms of anxiety and depression among individuals without a diagnosis remains an understudied area of research. METHODS: One hundred forty-three adults (52% female) completed the Trier Social Stress Test (TSST). Symptoms of depression and anxiety were assessed prior to the TSST using the anxiety and depression subscales of the Hospital Anxiety and Depression Scale (HADS). HPA axis responses were assessed by measuring salivary cortisol at baseline and following the TSST. Reactivity to and recovery from stress were assessed using multilevel growth modeling controlling for age, BMI, and sex among the full sample and a subset of cortisol responders (n = 72). RESULTS:Anxiety symptoms were positively associated with flatter recovery slopes among the full sample (t(122.3) = 2.082, p = .039). Among cortisol responders, depression symptoms were associated with steeper reactivity (t(63.32) = 2.53, p = .026) and recovery (t(58.75)=-2.20, p = .03). Anxiety symptoms were associated with marginally flatter reactivity (t(64.00)=-1.97, p = .053) and significantly flatter recovery (t(59.22) = 2.29, p = .025). CONCLUSION: Symptoms of anxiety and depression among individuals without a psychiatric diagnosis are associated with blunted and exaggerated cortisol responses to and recovery from stress. Such patterns could indicate increased risk for unhealthy HPA axis dysregulation, allostatic load, and disease.
Authors: Jelle V Zorn; Remmelt R Schür; Marco P Boks; René S Kahn; Marian Joëls; Christiaan H Vinkers Journal: Psychoneuroendocrinology Date: 2016-12-08 Impact factor: 4.905
Authors: Yuliya I Kuras; Christine M McInnis; Myriam V Thoma; Xuejie Chen; Luke Hanlin; Danielle Gianferante; Nicolas Rohleder Journal: Dev Psychobiol Date: 2016-08-30 Impact factor: 3.038
Authors: Ana Belén Fernández-Serrano; Francisco José Moya-Faz; Cesar Augusto Giner Alegría; Juan Carlos Fernández Rodríguez Journal: Brain Behav Date: 2022-05-19 Impact factor: 3.405
Authors: Rachel G Lucas-Thompson; Reagan L Miller; Natasha S Seiter; Mark A Prince Journal: Psychoneuroendocrinology Date: 2019-08-24 Impact factor: 4.905
Authors: Andres D Roque; Michelle G Craske; Michael Treanor; David Rosenfield; Thomas Ritz; Alicia E Meuret Journal: Psychoneuroendocrinology Date: 2020-03-07 Impact factor: 4.905